Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4(7)-Nitrobenzimidazole is a chemical compound that belongs to the nitrobenzenes family, characterized by the fusion of nitrogen and benzene elements in its molecular structure. It is a derivative of benzimidazole, a heterocyclic compound known for its chemical stability and diverse biological properties. 4(7)-NITROBENZIMIDAZOLE's potential applications in various fields are influenced by the nature and position of substituents within the benzimidazole system.

10597-52-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 10597-52-1 Structure
  • Basic information

    1. Product Name: 4(7)-NITROBENZIMIDAZOLE
    2. Synonyms: 4-nitro-1h-benzimidazol;4-nitro-benzimidazol;4-NITRO-1H-BENZIMIDAZOLE;4-NITROBENZIMIDAZOLE;4(7)-NITROBENZIMIDAZOLE;4-Nitro-1H-benzoimidazole;1H-Benzimidazole,4-nitro-(9CI);1H-Benzimidazole, 7-nitro-
    3. CAS NO:10597-52-1
    4. Molecular Formula: C7H5N3O2
    5. Molecular Weight: 163.13
    6. EINECS: N/A
    7. Product Categories: BENZIMIDAZOLE;pharmacetical
    8. Mol File: 10597-52-1.mol
  • Chemical Properties

    1. Melting Point: 238-239 °C
    2. Boiling Point: 475.7 °C at 760 mmHg
    3. Flash Point: 241.5 °C
    4. Appearance: /
    5. Density: 1.525 g/cm3
    6. Vapor Pressure: 9.35E-09mmHg at 25°C
    7. Refractive Index: 1.74
    8. Storage Temp.: 2-8°C
    9. Solubility: N/A
    10. PKA: 9.21±0.30(Predicted)
    11. CAS DataBase Reference: 4(7)-NITROBENZIMIDAZOLE(CAS DataBase Reference)
    12. NIST Chemistry Reference: 4(7)-NITROBENZIMIDAZOLE(10597-52-1)
    13. EPA Substance Registry System: 4(7)-NITROBENZIMIDAZOLE(10597-52-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 10597-52-1(Hazardous Substances Data)

10597-52-1 Usage

Uses

Used in Pharmaceutical Industry:
4(7)-Nitrobenzimidazole is used as a pharmaceutical compound for its potential anticancer, antiviral, and antibacterial properties. Its ability to modulate various biological pathways and target specific cellular processes makes it a promising candidate for the development of new therapeutic agents.
Used in Pesticide Industry:
In the pesticide industry, 4(7)-Nitrobenzimidazole is used as an active ingredient in the formulation of various pest control products. Its effectiveness in controlling pests and diseases in agricultural settings is attributed to its ability to disrupt essential biological processes in target organisms.
Used in Dye Industry:
4(7)-Nitrobenzimidazole is utilized in the dye industry for the synthesis of various colorants and pigments. Its chemical stability and compatibility with different substrates make it a valuable component in the production of dyes with specific color characteristics and performance properties.

Check Digit Verification of cas no

The CAS Registry Mumber 10597-52-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,5,9 and 7 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 10597-52:
(7*1)+(6*0)+(5*5)+(4*9)+(3*7)+(2*5)+(1*2)=101
101 % 10 = 1
So 10597-52-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H5N3O2/c11-10(12)6-3-1-2-5-7(6)9-4-8-5/h1-4H,(H,8,9)

10597-52-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-nitro-1H-benzimidazole

1.2 Other means of identification

Product number -
Other names Benzimidazole,4-nitro

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10597-52-1 SDS

10597-52-1Relevant articles and documents

Catalytic synthesis of benzimidazoles and organic carbamates using a polymer supported zinc catalyst through CO2 fixation

Biswas, Imdadul Haque,Biswas, Surajit,Islam, Md Sarikul,Riyajuddin, Sk,Sarkar, Priyanka,Ghosh, Kaushik,Islam, Sk Manirul

, p. 14643 - 14652 (2019)

Utilization of carbon dioxide in chemical fixation for synthesis of fine chemicals like benzimidazoles, organic carbamates, etc. is in high demand in recent years as carbon dioxide is a cost effective, sustainable, and green renewable C1 source. In this article we present the design and synthesis of an organically modified polystyrene bound heterogeneous [PS-Zn(ii)-SALTETA] catalyst. The catalyst has been characterized thoroughly by Fourier transform infrared spectroscopy, atomic absorption spectroscopy, thermo gravimetric analysis, PXRD, SEM and EDAX studies. The catalyst was used for cyclization of o-phenylenediamines through insertion of carbon dioxide in order to produce benzimidazoles in the presence of dimethylamine borane (DMAB). The developed catalytic procedure is sustainable, economical and efficient owing to the utilization of ethanol/water as a biodegradable and environment friendly solvent system. Besides benzimidazole production the catalyst was also very active for manufacture of organic carbamates from anilines and n-butyl bromide under atmospheric CO2 pressure under solvent free conditions at room temperature and the catalytic protocol showed outstanding functional group tolerance. Moreover the catalyst is highly recyclable and reusable.

Metal-Free Synthesis of Benzimidazoles via Oxidative Cyclization of d -Glucose with o-Phenylenediamines in Water

Raja, Dineshkumar,Philips, Abigail,Palani, Pushbaraj,Lin, Wei-Yu,Devikala, Sundaramurthy,Senadi, Gopal Chandru

, p. 11531 - 11540 (2020)

d-Glucose has been identified as an efficient C1 synthon in the synthesis of benzimidazoles from o-phenylenediamines via an oxidative cyclization strategy. Isotopic studies with 13C6-d-glucose and D2O unambiguously confirmed the source of methine. The notable features of this method include the following: broad functional group tolerance, a biorenewable methine source, excellent reaction yields, a short reaction time, water as an environmentally benign solvent, and the synthesis of vitamin B12 component on the gram scale.

Base substituted 5′-O-(N-isoleucyl)sulfamoyl nucleoside analogues as potential antibacterial agents

Gadakh, Bharat,Vondenhoff, Gaston,Lescrinier, Eveline,Rozenski, Jef,Froeyen, Mathy,Van Aerschot, Arthur

, p. 2875 - 2886 (2014)

Aminoacyl-sulfamoyl adenosines are well-known nanomolar inhibitors of the corresponding prokaryotic and eukaryotic tRNA synthetases in vitro. Inspired by the aryl-tetrazole containing compounds of Cubist Pharmaceuticals and the modified base as found in the natural antibiotic albomycin, the selectivity issue of the sulfamoylated adenosines prompted us to investigate the pharmacophoric importance of the adenine base. We therefore synthesized and evaluated several isoleucyl-sulfamoyl nucleoside analogues with either uracil, cytosine, hypoxanthine, guanine, 1,3-dideaza-adenine (benzimidazole) or 4-nitro-benzimidazole as the heterocyclic base. Based on the structure and antibacterial activity of microcin C, we also prepared their hexapeptidyl conjugates in an effort to improve their uptake potential. We further compared their antibacterial activity with the parent isoleucyl-sulfamoyl adenosine (Ile-SA), both in in vitro and in cellular assays. Surprisingly, the strongest in vitro inhibition was found for the uracil containing analogue 16f. Unfortunately, only very weak growth inhibitory properties were found as of low uptake. The results are discussed in the light of previous literature findings.

Synthesis and evaluation of analogs of 5′-(((Z)-4-amino-2-butenyl)methylamino)-5′-deoxyadenosine (MDL 73811, or AbeAdo) – An inhibitor of S-adenosylmethionine decarboxylase with antitrypanosomal activity

Brockway, Anthony J.,Volkov, Oleg A.,Cosner, Casey C.,MacMillan, Karen S.,Wring, Stephen A.,Richardson, Thomas E.,Peel, Michael,Phillips, Margaret A.,De Brabander, Jef K.

, p. 5433 - 5440 (2017)

We describe our efforts to improve the pharmacokinetic properties of a mechanism-based suicide inhibitor of the polyamine biosynthetic enzyme S-adenosylmethionine decarboxylase (AdoMetDC), essential for the survival of the eukaryotic parasite Trypanosoma brucei responsible for Human African Trypanosomiasis (HAT). The lead compound, 5′-(((Z)-4-amino-2-butenyl)methylamino)-5′-deoxyadenosine (1, also known as MDL 73811, or AbeAdo), has curative efficacy at a low dosage in a hemolymphatic model of HAT but displayed no demonstrable effect in a mouse model of the CNS stage of HAT due to poor blood–brain barrier permeation. Therefore, we prepared and evaluated an extensive set of analogs with modifications in the aminobutenyl side chain, the 5′-amine, the ribose, and the purine fragments. Although we gained valuable structure–activity insights from this comprehensive dataset, we did not gain traction on improving the prospects for CNS penetration while retaining the potent antiparasitic activity and metabolic stability of the lead compound 1.

An improved procedure for the synthesis of 1,3-dideazaadenosine

Devlin,Jebaratnam

, p. 711 - 718 (1995)

The preparation of the titled compound has been conveniently achieved in five steps, and in 43% overall yield. The large scale monoreduction of 2,6-dinitroaniline, and the stannic chloride catalyzed glycosylation of 4 to obtain 6 as the only product (86%) are two important reactions in this five step synthesis.

SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

-

Paragraph 00297; 00309-00310; 0074, (2021/04/01)

The invention provides substituted benzimidazole carboxamides and related compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat a medical disorder, e.g., cancer, lysosomal storage disorder, neurodegenerative disorder, inflammatory disorder, in a patient.

Microwave use of amidine compounds in the aqueous phase benzoate synthesis of benzimidazole compounds method

-

Paragraph 0095, (2019/03/28)

The invention discloses a microwave the use of amidine compounds in the aqueous phase benzoate synthesis of benzimidazole compounds, in the aqueous phase under microwave conditions adding benzoic amidine compound under alkaline condition [...] into benzimidazole reaction, invention an environment-friendly, the operation is simple, cheap and safe, efficient process for preparing benzimidazole method. Compared with the prior art, this method not only can be applied to a large number of functional groups, the productive rate is high, few by-products, and the operation is simple, safe, low cost, environmental protection; .

Cu@U-g-C3N4 Catalyzed Cyclization of o-Phenylenediamines for the Synthesis of Benzimidazoles by Using CO2 and Dimethylamine Borane as a Hydrogen Source

Phatake, Vishal V.,Bhanage, Bhalchandra M.

, p. 347 - 359 (2018/11/23)

Abstract: This work reports a green and sustainable route for the synthesis of benzimidazoles via C–N bond formation using carbon dioxide (CO2) as a C1 carbon source. In this work, Cu@U-g-C3N4 catalyst was prepared from urea derived porous graphitic carbon?nitride (U-g-C3N4) and CuCl2 and characterized by FT-IR, XRD, XPS, SEM, TPD etc. The Cu@U-g-C3N4 as a heterogeneous recyclable catalyst has been employed first time for the cyclization of o-phenylenediamines (OPD) with CO2 to benzimidazoles using dimethylamine borane (DMAB). The proposed protocol becomes sustainable and efficient due to the use of propylene carbonate/water as a suitable biodegradable, economical and environmentally benign solvent system. The proposed catalytic system showed a wide range of substrate scope for the synthesis of benzimidazoles in good to excellent yields. Graphical Abstract: [Figure not available: see fulltext.]

Atom-Specific Mutagenesis Reveals Structural and Catalytic Roles for an Active-Site Adenosine and Hydrated Mg2+ in Pistol Ribozymes

Neuner, Sandro,Falschlunger, Christoph,Fuchs, Elisabeth,Himmelstoss, Maximilian,Ren, Aiming,Patel, Dinshaw J.,Micura, Ronald

supporting information, p. 15954 - 15958 (2017/11/21)

The pistol RNA motif represents a new class of self-cleaving ribozymes of yet unknown biological function. Our recent crystal structure of a pre-catalytic state of this RNA shows guanosine G40 and adenosine A32 close to the G53–U54 cleavage site. While the N1 of G40 is within 3.4 ? of the modeled G53 2′-OH group that attacks the scissile phosphate, thus suggesting a direct role in general acid–base catalysis, the function of A32 is less clear. We present evidence from atom-specific mutagenesis that neither the N1 nor N3 base positions of A32 are involved in catalysis. By contrast, the ribose 2′-OH of A32 seems crucial for the proper positioning of G40 through a H-bond network that involves G42 as a bridging unit between A32 and G40. We also found that disruption of the inner-sphere coordination of the active-site Mg2+ cation to N7 of G33 makes the ribozyme drastically slower. A mechanistic proposal is suggested, with A32 playing a structural role and hydrated Mg2+ playing a catalytic role in cleavage.

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

-

Page/Page column, (2015/02/19)

Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 10597-52-1